Disease/Infection News

RSS

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Around the world, scientists race to develop a vaccine or treatment against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, a team of researchers has found that a drug already available around the world can kill the coronavirus in a lab setting in just 48 hours.

6 Apr 2020

Researchers create algorithm to protect surgical team members from COVID-19

Researchers from Stanford University's department of surgery have created an algorithm that aims to protect operating room team members who perform urgent and emergency operations from Coronavirus Disease 2019 (COVID-19) and rationally conserve the personal protective equipment they wear.

6 Apr 2020

Researchers tap Twitter data to measure success of social distancing

By comparing Twitter data from before and after the COVID-19 outbreak, Johns Hopkins University researchers found a profound impact on the movement of Americans – indicating social distancing recommendations are having an effect.

6 Apr 2020

Online hub for science journalists to find information on COVID-19

WFSJ-COVID-19-Briefing is an online hub where science journalists can find scientific information about the COVID-19 crisis and share best practices on covering this type of subject.

6 Apr 2020

McMaster: Common medical masks are good for most COVID-19 treatment

The N95 respirator masks should be preserved for health-care workers involved in inserting breathing tubes for patients with COVID-19. More common medical masks are fine for all other COVID-19 treatment, says preliminary research from McMaster University.

6 Apr 2020

Rush participates in clinical trial to test remdesivir as potential treatment for COVID-19

Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19). This disease currently has no approved treatment.

6 Apr 2020

Texas A&M chemists focus on searching for drugs to treat COVID-19

In the wake of the novel coronavirus pandemic, Texas A&M University chemist Wenshe Ray Liu and his research team have focused their lab solely on searching for drugs to treat COVID-19.

6 Apr 2020

Feel good music to lighten the lockdown and soothe self-isolation

A University professor - who is also a DJ and a global leader in the study of pop music - has drawn up a series of playlists that aim to lighten the lockdown and soothe self-isolation.

6 Apr 2020

New website provides updated information on antiviral options for COVID-19

The website, created by medical professionals from the Norwegian University of Science and Technology (NTNU) and St Olavs Hospital can be found at https://sars-coronavirus-2.info/.

6 Apr 2020

Mount Sinai launches web-based app to capture symptoms, spread of COVID-19 in New York City

A team of data scientists, physicians, and engineers across the Mount Sinai Health System has come together to launch STOP COVID NYC, a web-based app to capture the symptoms and spread of COVID-19 in New York City--currently the epicenter of the nation's largest outbreak.

6 Apr 2020

New antiviral drug could change the way doctors treat COVID-19

Scientists are hopeful that a new drug -- called EIDD-2801 -- could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.

6 Apr 2020

'Smart toilet' looks for signs of disease

A Stanford study published in the journal Nature Biomedical Engineering in April 2020 reports the development of a new kind of toilet that can pick up signs of an extensive range of diseases, from molecules in stool and urine. This could be extremely useful in repeatedly and inexpensively screening high-risk groups for certain conditions, including those for which a genetic tendency is possible – such as prostate cancer or certain kinds of kidney cancer.

6 Apr 2020

Scientist proposes geroprotective strategies to reduce lethality of COVID-19 in the elderly

The Biogerontology Research Foundation, a registered UK charity supporting and promoting aging and longevity research worldwide since 2008, today announced the publication of a paper titled "Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections" in the leading journal Aging.

6 Apr 2020

Cranfield University helps design simple, low-cost ventilators for critically-ill COVID-19 patients

A simple, low-cost Bag Valve Mask (BVM) ventilator to help critically-ill COVID-19 patients has been rapidly designed by experts at Cranfield University (UK) and built in Georgia Tech (USA) in a matter of days.

6 Apr 2020

Penn-led trial to evaluate the effectiveness of HCQ in combating COVID-19 pandemic

A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.

6 Apr 2020

After COVID-19: Doctors ponder best advice as patients recover from coronavirus

When David Vega fell ill with the novel coronavirus in mid-March, fever, chills and nausea left the 27-year-old Indiana medical student curled up in bed for days.

6 Apr 2020

Should US schools close to thwart spread of COVID-19?

A new study used mathematical modeling to explore the benefits and risks of closing down the schools to prevent new cases and the possibility of absenteeism among health care workers because they need to care for their children at home and the ultimate effect of the step on reducing the risk of deaths due to COVID-19.

6 Apr 2020